998 resultados para Flavobacterium columnare G4
Resumo:
Biological studies are necessary for the management of wildlife in captivity, and knowledge of reproduction is one of the important features for increasing production. The objective of the research was to determine the age at which male collared peccaries reach puberty. Testicular samples of 15 animals, aged 7 to 16 months, distributed into five groups (G1, G2, G3, G4 and G5) were used. The testes showed considerably increased weight, length and width (p < 0.05) from G1 to G3, whereas, from this group onward, the development of this organ was slower. There was positive correlation (p < 0.001) between the following testicular parameters: weight and length (r = 0.97), weight and width (r = 0.88), length and width (r = 0.92). Regarding the diameter of seminiferous tubules, an increase was observed (p < 0.05) from G1 to G4. The total number of spermatogenic cells increased significantly (p < 0.05) until G3 and then it stabilized. There was also positive correlation between testis weight and tubular diameter (r = 0.99, p < 0.001), and testis weight and spermatogenic cells (r = 0.98, p < 0.001). The number of Sertoli cells decreased significantly (p < 0.05) from G1, when they were undifferentiated as support cells, to G5, when they occurred together with the complete line of spermatic cells. The results demonstrate that the reproductive development of peccaries can be classified into the following stages: impuberty (G1, 7-8 months); pre-pubertal (G2, 9-10 months); pubertal (G3, 11-12 months); post-pubertal 1 (G4, 13-14 months); and post-pubertal 2 (G5, 15-16 months). Based on the histological analyses, puberty in the male collared peccary was determined to occur between 11 and 12 months of age.
Resumo:
Objetivo: Analisar as funções executivas de idosos com doença de Parkinson (DP – com e sem quadro demencial) e doença de Alzheimer (DA), e confrontar os escores dos participantes no que se refere às atividades funcionais da vida diária e à habilidade motora em situações de dupla tarefa. Métodos: Sob um desenho transversal, 54 idosos foram divididos em quatro grupos: G1, composto por 11 sujeitos com DP; G2, formado por 10 sujeitos com demência de Parkinson; G3, composto por 13 participantes com DA; e G4, formado por 20 idosos saudáveis. Os procedimentos metodológicos envolveram análise das funções cognitivas pré-frontais dos sujeitos, da realização das atividades da vida diária e da habilidade motora em situações de dupla tarefa. A análise dos dados envolveu a estatística descritiva (média e erro-padrão) e inferencial (teste ANOVA e pós-teste de Scheffé), admitindo significância de 5% (p < 0,05) e intervalo de confiança de 95%. Resultados: As funções cognitivas pré-frontais apresentaram diferença significativa entre os grupos, sobretudo nas comparações envolvendo G2 e G3, em relação a G1 e G4 (p = 0,001). Os grupos com déficit cognitivo apresentaram pior rendimento na realização das atividades da vida diária, com menor escore do G2, na qual há junção de déficit cognitivo e motor (p = 0,001). Em situações de dupla tarefa, G2 e G3 apresentaram maiores dificuldades que os demais grupos (p < 0,05). Conclusão: Distúrbios pré-frontais repercutem negativamente nas atividades funcionais e na habilidade psicomotora dos indivíduos. Quando não vinculado a quadro demencial, os pacientes com DP apresentaram escores cognitivos pré-frontais e independência funcional semelhantes aos de idosos saudáveis.
Resumo:
FUNDAMENTO: A sedação com midazolam e meperidina é amplamente utilizada em ecocardiografia transesofágica, entretanto, não existe dose média estabelecida para cada caso. OBJETIVO: Correlacionar as doses médias de midazolam e meperidina para sedação adequada em ecocardiografia transesofágica com faixa etária, área de superfície corpórea e fração de ejeção do ventrículo esquerdo. MÉTODOS: Estudo retrospectivo envolvendo 1.841 pacientes submetidos à sedação baseada na escala de Ramsay, com solução contendo midazolam 1,5 mg (1,5 ml), meperidina 1 mg (1 ml) e água destilada (7,5 ml). Analisamos quatro grupos etários: G1: < 24 anos; G2: 25 a 44 anos; G3: 45 a 64 anos; e G4: > 65 anos. Obtivemos a área de superfície corpórea pela fórmula: {[(altura x 100)0,725] x (peso0,425) x 0,0071}. Com relação à fração de ejeção do ventrículo esquerdo, estudamos dois grupos: GA: < 55%; e GB: > 55%. Na análise estatística utilizamos o teste de Kruskal-Wallis para correlação com idade e fração de ejeção do ventrículo esquerdo, e correlação linear simples para área de superfície corpórea. RESULTADOS: No estudo da idade, as doses médias de sedação necessárias foram significativamente menores no G3 e G4 (p < 0,01). Na análise da fração de ejeção do ventrículo esquerdo, esta foi significativamente menor no GA (p < 0,01). O coeficiente de correlação linear entre dose de sedação e área de superfície corpórea foi 0,09 (nulo). CONCLUSÃO: Houve menor dose média necessária de sedativos nos indivíduos com maior idade e em portadores de disfunção sistólica do ventrículo esquerdo, e não houve correlação com área de superfície corpórea.
Resumo:
FUNDAMENTO: Os valores de referência de teste cardiopulmonar (TCP) disponíveis no Brasil foram derivados de cicloergômetro, em população sedentária e relativamente pequena. OBJETIVO: Fornecer valores de referência para o TCP em brasileiros de ambos os sexos, sedentários e ativos. MÉTODOS: ENtre 2006 e 2008, 3.992 TCP de indivíduos saudáveis foram selecionados de nosso laboratório. Atletas, fumantes, portadores de qualquer patologia conhecida, usuários de medicação contínua e obesos foram excluídos. VO2 pico foi considerado VO2 máx. Analisamos também VO2 de limiar anaeróbico, ventilação máxima e pulso de oxigênio de acordo com sexo, faixa etária, sedentários e ativos. As faixas etárias foram assim divididas: G1 (15-24 anos), G2 (25-34), G3 (35-44), G4 (45-54), G5 (55-64) e G6 (65-74). RESULTADOS: De acordo com as faixas etárias, os valores médios de VO2 em ml/kg/min com os respectivos desvios-padrão foram: Homem ativo: G1-50,6 ± 7,3; G2-47,4 ± 7,4; G3-45,4 ± 6,8; G4-40,5 ± 6,5; G5-35,3 ± 6,2; G6-30,0 ± 6,1. Mulher ativa: G1-38,9 ± 5,7; G2-38,1 ± 6,6; G3-34,9 ± 5,9; G4-31,1 ± 5,4; G5-28,6 ± 6,1; G6-25,1 ± 4,4. Homem sedentário: G1-47,4 ± 7,9; G2-41,9 ± 7,2; G3-39,0 ± 6,8; G4-35,6 ± 7,7; G5-30,0 ± 6,3; G6-23,1 ± 6,3. Mulher sedentária: G1-35,6 ± 5,7; G2-34,0 ± 4,8; G3-30,0 ± 5,4; G4-27,2 ± 5,0; G5-23,9 ± 4,2; G6-21,2 ± 3,4. CONCLUSÃO: ESte artigo fornece valores de referência de VO2 máx, entre outros parâmetros, no Teste Cardiopulmonar realizados na esteira ergométrica em indivíduos de ambos os sexos, ativos e sedentários.
Resumo:
Background: Pitavastatin is the newest statin available in Brazil and likely the one with fewer side effects. Thus, pitavastatin was evaluated in hypercholesterolemic rabbits in relation to its action on vascular reactivity. Objective: To assess the lowest dose of pitavastatin necessary to reduce plasma lipids, cholesterol and tissue lipid peroxidation, as well as endothelial function in hypercholesterolemic rabbits. Methods: Thirty rabbits divided into six groups (n = 5): G1 - standard chow diet; G2 - hypercholesterolemic diet for 30 days; G3 - hypercholesterolemic diet and after the 16th day, diet supplemented with pitavastatin (0.1 mg); G4 - hypercholesterolemic diet supplemented with pitavastatin (0.25 mg); G5 - hypercholesterolemic diet supplemented with pitavastatin (0.5 mg); G6 - hypercholesterolemic diet supplemented with pitavastatin (1.0 mg). After 30 days, total cholesterol, HDL, triglycerides, glucose, creatine kinase (CK), aspartate aminotransferase (AST), alanine aminotransferase (ALT) were measured and LDL was calculated. In-depth anesthesia was performed with sodium thiopental and aortic segments were removed to study endothelial function, cholesterol and tissue lipid peroxidation. The significance level for statistical tests was 5%. Results: Total cholesterol and LDL were significantly elevated in relation to G1. HDL was significantly reduced in G4, G5 and G6 when compared to G2. Triglycerides, CK, AST, ALT, cholesterol and tissue lipid peroxidation showed no statistical difference between G2 and G3-G6. Significantly endothelial dysfunction reversion was observed in G5 and G6 when compared to G2. Conclusion: Pitavastatin starting at a 0.5 mg dose was effective in reverting endothelial dysfunction in hypercholesterolemic rabbits.
Resumo:
A partir de 154 espécimens de alimentos, representados por hortaliças (alface), leite e merenda escolar, obteve-se o isolamento e identificação de 400 amostras de bacilos Gram negativos. Esta amostragem se distribuiu em 339 enterobactérias (Escherichia, Shigella, Citrobacter, Klebsiella, Enterobacter, Serratia e Proteus) e 61 de gêneros afins (Acinetobacter, Flavobacterium, Aeromonas e Pseudomonas). Submetendo-se as culturas aos antimicrobianos: sulfadiazina (Su), estreptomicina (Sm), tetraciclina (Tc), cloranfenicol (Cm), canamicina (Km), ampicilina (Ap), ácido nalidíxico (Nal) e gentamicina (Gm), observou-se apenas seis estirpes sensíveis a todas as drogas e sensibilidade absoluta à Gm. A predominância dos modelos Su (27,6%) e Su-Ap (39,6%) incidiu nas enterobactérias, enquanto que, 18,0% para Ap e 9,8% para Su-Ap foram detectados nos gêneros afins. Para caracterização da resistência foram realizados testes de conjugação e a totalidade das culturas não revelou transferência para o gene que confere resistência ao ácido nalidíxico. Relevantes são as taxas de amostras R+ observadas nos bacilos entéricos, oscilando em torno de 90% (leite e merenda escolar) e alface, em torno de 70%
Resumo:
This study sought the characterization of rotaviruses in a trial with a tetravalent rhesus-human rotavirus vaccine in Belém, Brazil in children who received three doses of vaccine or placebo in the 1st, 3rd and 5th months of life. Rotavirus electropherotypes, subgroups, G serotypes, G, [P] and [P],G genotypes were determined in 93.3%, 95.9%, 93.3%, 73.3%, 95.5% and 92.2% of isolates, respectively. Serotypes G1, G2 and G4 were detected in 58.9%, 30% and 4.4% of the cases, respectively. Rotavirus genotype G5 was detected for the first time in Northern region in 4.4% of the infections. Rotavirus genotypes P[8], P[4], P[6] and P[8+6] were detected in 54.5%, 26.7%, 12.2%, and 2.2% of the cases, respectively. The predominant genotypes were P[8],G1 and P[4],G2 with 53% and 26.6% of the infections, respectively. Unusual strains accounted for 20.5% including P[4],G1, P[6],G1, P[6],G4, P[6],G5, P[8],G2, P[8],G5. Mixed infections involving P[8+6],G2 and P[8+6],G1 were also noted. The neonatal P[6] strains associated with diarrhea were detected among children aged 9-24 months. To our knowledge, this study represents the first in Brazil to analyse, on molecular basis, rotavirus genotypes from children participating in a rotavirus vaccine trial. These results are of potential importance regarding future rotavirus vaccination strategies in Brazil.
Resumo:
A ribosome association factor (AF) was isolated from the yeast Sacchharomyces cerevisiae. Partial amino acid sequence of AF was determined from its fragment of 25 kDa isolated by treating AF with 2-(2-nitrophenylsulfenyl)-3-methyl-3'-Bromoindolenine (BNPS-skatole). This sequence has a 86% identity to the product of the single-copy S. cerevisiae STM1 gene that is apparently involved in several events like binding to quadruplex and triplex nucleic acids and participating in apoptosis, stability of telomere structures, cell cycle, and ribosomal function. Here we show that AF and Stm1p share some characteristics: both bind to quadruplex and Pu triplex DNA, associates ribosomal subunits, and are thermostable. These observations suggest that these polypeptides belong to a family of proteins that may have roles in the translation process.
Resumo:
RotaTeq® (Merck & Company, Inc, Whitehouse Station, NJ, USA) is an oral pentavalent rotavirus vaccine (RV5) that has shown high and consistent efficacy in preventing rotavirus gastroenteritis (RGE) in randomised clinical trials previously conducted in industrialised countries with high medical care resources. To date, the efficacy and effectiveness data for RV5 are available in some Latin American countries, but not Brazil. In this analysis, we projected the effectiveness of RV5 in terms of the percentage reduction in RGE-related hospitalisations among children less than five years of age in four regions of Brazil, using a previously validated mathematical model. The model inputs included hospital-based rotavirus surveillance data from Goiânia, Porto Alegre, Salvador and São Paulo from 2005-2006, which provided the proportions of rotavirus attributable to serotypes G1, G2, G3, G4 and G9, and published rotavirus serotype-specific efficacy from the Rotavirus Efficacy and Safety Trial. The model projected an overall percentage reduction of 93% in RGE-related hospitalisations, with an estimated annual reduction in RGE-related hospitalisations between 42,991-77,383 in the four combined regions of Brazil. These results suggest that RV5 could substantially prevent RGE-related hospitalisations in Brazil.
Resumo:
PURPOSE: To compare the effect of a rat anti-VEGF antibody, administered either by topical or subconjunctival (SC) routes, on a rat model of corneal transplant rejection.METHODS: Twenty-four rats underwent corneal transplantation and were randomized into four treatment groups (n=6 in each group). G1 and G2 received six SC injections (0.02 ml 10 µg/ml) of denatured (G1) or active (G2) anti-VEGF from Day 0 to Day 21 every third day. G3 and G4 were instilled three times a day with denatured (G3) or active (G4) anti-VEGF drops (10 µg/ml) from Day 0 to Day 21. Corneal mean clinical scores (MCSs) of edema (E), transparency (T), and neovessels (nv) were recorded at Days 3, 9, 15, and 21. Quantification of neovessels was performed after lectin staining of vessels on flat mounted corneas.RESULTS: Twenty-one days after surgery, MCSs differed significantly between G1 and G2, but not between G3 and G4, and the rejection rate was significantly reduced in rats receiving active antibodies regardless of the route of administration (G2=50%, G4=66.65% versus G1 and G3=100%; p<0.05). The mean surfaces of neovessels were significantly reduced in groups treated with active anti-VEGF (G2, G4). However, anti-VEGF therapy did not completely suppress corneal neovessels.CONCLUSIONS: Specific rat anti-VEGF antibodies significantly reduced neovascularization and subsequent corneal graft rejection. The SC administration of the anti-VEGF antibody was more effective than topical instillation.
Resumo:
Dans les sols infestés avec Macrophomina phaseolina les semences de niébé ne germent pas ou bien la plantule est détruite plus ou moins rapidement après la germination. Clonostachys rosea est un champignon commun du sol reconnu comme un saprophyte avec une haute capacité de compétition sur les racines et dans le sol. Notre étude a pour objectif d’évaluer l’effet de C. rosea en traitement de semences du niébé conservées à 40°C sur le développement de la pourriture charbonneuse. L’effet de la durée de conservation sur la viabilité des spores et le pouvoir antagonique du bioagent a également été étudié dans les conditions semi contrôlé et au champ. Les isolats de C. rosea proviennent de la collection du laboratoire de phytopathologie de AGRHYMET. La production des spores a été effectuée sur le milieu PDA pendant 4 semaines. Les semences du niébé ont été traitées avec une suspension de spores à la concentration de 108 spores / ml à raison de 5 ml de suspension par kg de semences. Les semences traitées ont été séchées sous la hotte à flux laminaire pendant 2 h avant d’être semées ou conservées à 40°C. Des tests de viabilité des spores de C. rosea sur le milieu de culture PDA ont été effectués au laboratoire tous les 15 jours de conservation. Le taux de germination des semences sur papier buvard, évalué au cinquième jour après semis au laboratoire a été de 99 %. La forte moyenne de spores viables au jour de l’enrobage (J0) (>4,5 105), a chuté à 1700 spores par graines après 75 jours de conservation. En serre, le niveau de colonisation des tissus des plants de niébé se développant sur le sol infesté a été significativement plus faible chez les plants issus de graines enrobées (1009 microsclérotes/g tissus) que chez ceux issus de graines non enrobées (2356 microsclérotes/g tissus). Par rapport a la sévérité de la maladie, exprimée sur une échelle de 1-5, ont été notées une forte infection des plants du témoin Macrophomina (graines non traitées semées dans un sol infesté) et des attaques moins sévères sur les traitements G3M et G4M (graines traitées semées dans un sol infesté). Au champ dans l’essai semé avec des graines enrobées mais non conservées, l’association des isolats G3 et G4 a été nettement supérieure aux autres traitements par rapport aux rendements en fane et en graines. Par contre, par rapport au rendement, aucun effet des traitements n’a été observé dans l’essai semé avec les graines conservées pendant 30 jours.
Resumo:
CONTEXT: A broad spectrum of GnRH-deficient phenotypes has been identified in individuals with both mono- and biallelic GNRHR mutations. OBJECTIVE: The objective of the study was to determine the correlation between the severity of the reproductive phenotype(s) and the number and functional severity of rare sequence variants in GNRHR. SUBJECTS: Eight hundred sixty-three probands with different forms of GnRH deficiency, 46 family members and 422 controls were screened for GNRHR mutations. The 70 subjects (32 patients and 38 family members) harboring mutations were divided into four groups (G1-G4) based on the functional severity of the mutations (complete or partial loss of function) and the number of affected alleles (monoallelic or biallelic) with mutations, and these classes were mapped on their clinical phenotypes. RESULTS: The prevalence of heterozygous rare sequence variants in GNRHR was significantly higher in probands vs. controls (P < 0.01). Among the G1-G3 groups (homozygous subjects with successively decreasing severity and number of mutations), the hypogonadotropic phenotype related to their genetic load. In contrast, subjects in G4, with only monoallelic mutations, demonstrated a greater diversity of clinical phenotypes. CONCLUSIONS: In patients with GnRH deficiency and biallelic mutations in GNRHR, genetic burden defined by severity and dose is associated with clinical phenotype. In contrast, for patients with monoallelic GNRHR mutations this correlation does not hold. Taken together, these data indicate that as-yet-unidentified genetic and/or environmental factors may combine with singly mutated GNRHR alleles to produce reproductive phenotypes.
Resumo:
[Iliade (français). Extrait. 1545]
Resumo:
[Iliade (français). Extrait. 1545]